The investigation of FGF23, a prognostic factor in children with chronic kidney disease and bone metabolism

The investigation of FGF23, a prognostic factor in children with chronic kidney disease and bone metabolism - The investigation of FGF23 and bone metabolism in children with CKD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028891

Enrollment

200

Registered

2017-08-30

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic kidney disease (including renal transplant recipients)

Exclusion criteria

Exclusion criteria: The patients who does not agree with this study. The patients with anemia whose Hb levels are less than 8 g/dl

Design outcomes

Primary

Measure	Time frame
Increase or decrease and the balance of FGF23 production and degradation	—

Secondary

Measure	Time frame
bone metabolism, iron metabolism, inflammation and renal function	—

Countries

Japan

Contacts

Public ContactNatsumi Yamamura

Osaka Women's and Children's Hospital Department of Pediatric Nephrology and Metabolism

yamamur@wch.opho.jp0725561220

Outcome results